Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Enanta Pharmaceuticals Inc.

Initiate a Phase 1 clinical study of EDP-721

Delivered after the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
8 Feb 2021
Due
30 Jun 2021
Delivered
by 9 Aug 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Enanta expects to initiate a Phase 1 clinical study of EDP-721 in mid-2021.”

What we found

Evidence strength A What the grades mean

The company reported initiating the Phase 1 clinical study of EDP-721 in its August 2021 filing, which occurred after the mid-2021 deadline.

  • A
    Enanta Pharmaceuticals Inc. 10-Q filed 2021-08-09 Regulatory filing · published 9 Aug 2021 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint 7e29df8a45bf
    “For our RNA destabilizer, we have initiated a Phase 1 clinical study of EDP-721 and are on track to dose our first subject in August 2021.” ✓ confirmed on the page

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical milestone
Indicative materiality
Medium rules
Action
Initiate
Deliverable
Phase 1 clinical study of EDP-721
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Enanta Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-ENTA-023285 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.